UK markets closed

Vistin Pharma ASA (0RAM.L)

LSE - LSE Delayed price. Currency in NOK
Add to watchlist
24.30+0.40 (+1.67%)
At close: 09:05AM BST
Currency in NOK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.90
52-week change 33.40%
S&P500 52-week change 321.61%
52-week high 324.40
52-week low 30.00
50-day moving average 323.21
200-day moving average 323.21

Share statistics

Avg vol (3-month) 3886
Avg vol (10-day) 31k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 818.91M
% held by insiders 154.76%
% held by institutions 112.77%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.00
Trailing annual dividend yield 34.18%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 10.41%
Operating margin (ttm)18.53%

Management effectiveness

Return on assets (ttm)10.64%
Return on equity (ttm)15.31%

Income statement

Revenue (ttm)438.33M
Revenue per share (ttm)9.88
Quarterly revenue growth (yoy)-0.20%
Gross profit (ttm)N/A
EBITDA 85.94M
Net income avi to common (ttm)45.64M
Diluted EPS (ttm)0.56
Quarterly earnings growth (yoy)6.70%

Balance sheet

Total cash (mrq)26.2M
Total cash per share (mrq)0.59
Total debt (mrq)3.3M
Total debt/equity (mrq)1.02%
Current ratio (mrq)2.54
Book value per share (mrq)7.28

Cash flow statement

Operating cash flow (ttm)88.1M
Levered free cash flow (ttm)35.1M